beta
/ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial
Abstract

Abstract N/A

RelatedView All
CitationsView All
Citing15
Cited By-